Doxorubicin Hydrochloride
- Product NDC
- 70860-208
- 11-digit product format
- 708600208
- Labeler code
- 70860
- Product ID
- 70860-208_93ce419e-e621-46a8-9e35-b818a569a18a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- doxorubicin hydrochloride
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Application
- ANDA209825
- Marketing category
- ANDA
- Marketing start
- 2017-10-20
- Marketing end
- 0000-00-00
- Substance
- DOXORUBICIN HYDROCHLORIDE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [CS],Topoisomerase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70860-208-05 | 70860020805 | 1 VIAL, SINGLE-DOSE in 1 CARTON (70860-208-05) > 5 mL in 1 VIAL, SINGLE-DOSE | 2017-10-20 | 0000-00-00 | No | No | Current |
| 70860-208-25 | 70860020825 | 1 VIAL, SINGLE-DOSE in 1 CARTON (70860-208-25) > 25 mL in 1 VIAL, SINGLE-DOSE | 2017-10-20 | 0000-00-00 | No | No | Current |
| 70860-208-51 | 70860020851 | 1 VIAL, MULTI-DOSE in 1 CARTON (70860-208-51) > 100 mL in 1 VIAL, MULTI-DOSE | 2017-10-20 | 0000-00-00 | No | No | Current |